ADIAL PHARMACEUTICALS, INC. (ADIL) (CIK 0001513525) CORRESP

ADIAL PHARMACEUTICALS, INC. (ADIL) (CIK 0001513525) → SEC staff · filed 2025-12-15 · ticker ADIL · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001213900-25-121686
Form
CORRESP
Filer
ADIAL PHARMACEUTICALS, INC. (ADIL) (CIK 0001513525)
CIK
0001513525
Ticker
ADIL
Filed
2025-12-15
SIC industry
2834
HQ
Charlottesville, VA

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1513525/000121390025121686/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗